Evercore ISI lowered the firm’s price target on Morgan Stanley to $97 from $99 and keeps an Outperform rating on the shares. While “well-enough telegraphed” and not too unique to Morgan Stanley, Q4 returns were “nothing to write home about,” the analyst tells investors. While the dialogue around near-term NII and Wealth Management margins “is a bummer and underscores the importance of that high incremental margin revenue,” none of the firmwide goals changed, notes the analyst, who thinks better investment banking, wealth and asset management fees, and higher client engagement “all help to keep MS a stable & secular growth story.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MS: